First Experience with Osimertinib in Patients with Newly Developed T790M Mutation Previously Treated with EGFR - TKIs in Croatia

被引：0
|
作者：
Jakopovic, M. [1 ]
Bitar, L. [1 ]
Seiwerth, F. [1 ]
Plestina, S. [1 ]
Kukulj, S.
Seiwerth, S. [2 ,3 ]
Misic, M. [3 ]
Redzepi, G. [1 ]
Samarzija, M. [2 ]
机构：
[1] Univ Hosp Ctr Zagreb, Dept Resp Dis Jordanovac, Zagreb, Croatia
[2] Univ Hosp Ctr Zagreb, Zagreb, Croatia
[3] Univ Hosp Ctr Zagreb, Clin Dept Pathol, Zagreb, Croatia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
D O I：
10.1016/j.jtho.2017.09.1500
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-059
引用
收藏
页码：S2224 / S2224
页数：1
相关论文
共 50 条
  • [1] First experience with osimertinib in patients with T790M mutation previously treated with EGFR TKIs in Croatia.
    Jakopovic, Marko
    Bitar, Lela
    Cucevic, Branka
    Plestina, Sanja
    Mazuranic, Ivica
    Seiwerth, Sven
    Hecimovic, Ana
    Dugac, Andrea Vukic
    Jankovic, Mateja
    Redzepi, Gzim
    Samarzija, Miroslav
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Osimertinib Expanded Access Program for Previously Treated Patients With Advanced EGFR T790M Mutation-Positive NSCLC
    Santos, Edgardo
    Kaplan, Barry
    Kirshner, Eli
    Croft, Elisabeth
    Sequist, Lecia
    Burke, Lea
    Munley, Jiefen
    Oxnard, Geoffrey
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1237 - S1237
  • [3] Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation
    Luo, Yung-Hung
    Liu, Han
    Wampfler, Jason A.
    Tazelaar, Henry D.
    Li, Yalun
    Peikert, Tobias
    Liu, Dan
    Leventakos, Konstantinos
    Chen, Yuh-Min
    Yang, Yanan
    Chiou, Shih-Hwa
    Yang, Ping
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (08) : 2099 - 2114
  • [4] Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M
    Zhao, S.
    Jiang, T.
    Li, X.
    Zhao, C.
    Su, C.
    Ren, S.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S410 - S410
  • [5] Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation
    Yung-Hung Luo
    Han Liu
    Jason A. Wampfler
    Henry D. Tazelaar
    Yalun Li
    Tobias Peikert
    Dan Liu
    Konstantinos Leventakos
    Yuh-Min Chen
    Yanan Yang
    Shih-Hwa Chiou
    Ping Yang
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2099 - 2114
  • [6] Association between clinical outcome of first EGFR-TKIs and T790M mutation in NSCLC patients harboring EGFR mutation with acquired resistance to EGFR-TKIs.
    Oya, Yuko
    Yoshida, Tatsuya
    Tanaka, Kosuke
    Shimizu, Junichi
    Horio, Yoshitsugu
    Sakao, Yukinori
    Hida, Toyoaki
    Yatabe, Yasushi
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Association between clinical outcome of first EGFR-TKIs and T790M mutation in NSCLC patients harboring EGFR mutation with acquired resistance to EGFR-TKIs
    Oya, Y.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S622 - S622
  • [8] Therapy with Osimertinib in Patients with T790M Mutation: Experience of a Portuguese Oncology Center
    Azevedo Pereira, I.
    Vieira, I.
    Rodrigues, A.
    Pousa, I.
    Oliveira, J.
    Cassiano, M.
    Oliveira, C.
    Rosinha, A.
    Azevedo, I.
    Soares, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S667 - S667
  • [9] EGFR T790M resistance mutation in NSCLC: Real-life data of patients treated with osimertinib.
    Hochmair, Maximilian J.
    Holzer, Sophia
    Filipits, Martin
    Mohn-Staudner, Andrea
    Arns, Madeleine
    Errhalt, Peter
    Absenger, Gudrun
    Koller-Herzog, Ursula
    Setinek, Ulrike
    Haslbauer, Ferdinand
    Korger, Mark A.
    Patocka, Kurt
    Kolb, Rainer
    Burghuber, Otto
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] EGFR T790M Resistance Mutation in NSCLC: Real-Life Data of Austrian Patients Treated with Osimertinib
    Hochmair, Maximilian
    Holzer, Sophia
    Filipits, Martin
    Mohn-Staudner, Andrea
    Errhalt, Peter
    Absenger, Gudrun
    Bundalo, Tatjana
    Arns, Madeleine
    Setinek, Ulrike
    Mikes, Romana
    Kolb, Rainer
    Schumacher, Michael
    Zoechbauer-Mueller, Sabine
    Patocka, Kurt
    Haslbauer, Ferdinand
    Rudzki, Jakob
    Burghuber, Otto
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1254 - S1254
12345